AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells (Q89068393)
Jump to navigation
Jump to search
scientific article published on 11 June 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells |
scientific article published on 11 June 2018 |
Statements
AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells (English)
Paul C Trippier
1 reference
Nehal Gupta
Tianzhu Zang
Phumvadee Wangtrakluldee
Sanjay K Srivastava